Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases - Wikidata - awgldk - TriplyDB

Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases

Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases

http://www.wikidata.org/entity/Q28383084

about

Algae-based oral recombinant vaccines Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening Antimicrobial polymeric materials with quaternary ammonium and phosphonium salts Serotype 1-Specific Monoclonal Antibody-Based Antigen Capture Immunoassay for Detection of Circulating Nonstructural Protein NS1: Implications for Early Diagnosis and Serotyping of Dengue Virus Infections Path of infectious diseases in Brazil in the last 50 years: an ongoing challenge Liberty to decide on dual use biomedical research: an acknowledged necessity.Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges.Reflections on pandemic (H1N1) 2009 and the international response.High-throughput screening of a diversity collection using biodefense category A and B priority pathogens EPIMIC: A Simple Homemade Computer Program for Real-Time EPIdemiological Surveillance and Alert Based on MICrobiological Data.Death certificates underestimate infections as proximal causes of death in the U.S.Future trends and challenges in pathogenomics. A Foresight study.The development of a GeXP-based multiplex reverse transcription-PCR assay for simultaneous detection of sixteen human respiratory virus types/subtypes.Interspecies protein-protein interaction network construction for characterization of host-pathogen interactions: a Candida albicans-zebrafish interaction study.Risk assessment for invasive species produces net bioeconomic benefits Pricing infectious disease. The economic and health implications of infectious diseases.Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice.Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.Years of life lost due to infectious diseases in Poland Delivery systems and adjuvants for oral vaccines.Epithelial cell lines of the cotton rat (Sigmodon hispidus) are highly susceptible in vitro models to zoonotic Bunya-, Rhabdo-, and Flaviviruses.Perspectives of public health laboratories in emerging infectious diseases.Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease.The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays.Efficacy of Aqueous and Methanolic Extracts of Rheum Spiciformis against Pathogenic Bacterial and Fungal Strains.Use of infliximab in particular clinical settings: management based on current evidence.Regulating toxin-antitoxin expression: controlled detonation of intracellular molecular timebombs Exploitation of the Macrophage Mannose Receptor (CD206) in Infectious Disease Diagnostics and Therapeutics.Antimicrobial and Hemolytic Studies of a Series of Polycations Bearing Quaternary Ammonium Moieties: Structural and Topological Effects.Insights into antibiotic resistance through metagenomic approaches.A novel cardiac bio-marker: ST2: a review.Academic I.D. in jeopardy: the erosion of time, professional values, and physician satisfaction.Oxazolidinone antimicrobials: a patent review (2012-2015).Predictive models of control strategies involved in containing indoor airborne infections.Characterization and antipathogenic evaluation of a novel quaternary phosphonium tripolyacrylamide and elucidation of the inactivation mechanisms.Evaluation of a multiplexed PCR assay for detection of respiratory viral pathogens in a public health laboratory setting.A two-tube multiplex reverse transcription PCR assay for simultaneous detection of sixteen human respiratory virus types/subtypes.5-Hydroxymethyl-oxazolidin-2-one antibacterials. Actelion Pharmaceuticals: WO2008062379.Antimicrobial Activities and Time-Kill Kinetics of Extracts of Selected Ghanaian Mushrooms.The challenges of implementing an integrated One Health surveillance system in Australia.

P2860

Q21131110-2C47F143-A3A8-47E7-A9B2-3C544B75F847 Q24651907-107021E3-B804-436A-A9F1-C1F8818A8B88 Q27021973-27969044-B378-4C2A-A1D8-540AA9FB6797 Q27477501-7C143650-A827-4E97-AABA-440316281B5D Q28119671-665DC60C-95E5-46E5-8259-2E911FF93241 Q30228972-7FBD02E4-733B-481C-9E40-F7AA776CC890 Q30235317-DBA263E7-5B93-4671-B812-71E22603D157 Q30395014-DCA7C671-729B-4A32-8CD4-2012DC0B6A47 Q30541139-6798F803-AB08-46BD-B53C-29D4AC87A8F9 Q31031679-330E5AD8-D007-4C4B-AE2C-E11BA5206CE6 Q33689938-BC706BDD-6F40-4B52-97A4-B5490A1FF0F2 Q34360398-CE93AABC-D0D6-4230-8DF3-E8EC3BD8EB6D Q34379279-7BF4572C-661F-4F74-8634-1D9745A9A31C Q34942661-F57529F4-4C05-4430-9439-C0E09B576E56 Q35575927-5017D005-672D-4140-8836-899CB4729E33 Q35891864-825BBA86-3518-4795-8481-E2C48D30FD46 Q36126206-373682CA-8C34-4A55-9BD3-B5EEF6A1FDE8 Q36261750-352A51FB-62D1-4C71-8FBA-83AE406217B8 Q36319905-0E13144D-397D-4207-B54E-B150A0B4A3E9 Q36640326-176E2BBF-0CA3-4278-9F5B-06F44768F757 Q36866624-6D8F99B9-2C33-4069-BB7D-4E8EA9234FD0 Q36969626-E8AD7FB6-ACB5-43BB-9C59-6D986A7C2008 Q36974999-52D7E3F9-BD37-4245-95CA-05C5ED0B8CAC Q37169163-1F7D21B6-5C38-4D1F-9CAC-B901045F9A46 Q37352908-C76EFDB8-BDAC-4870-BC57-6322266D0C23 Q37506064-5593F3E4-9D1F-445F-8FD3-ADF420B0278E Q37576199-05265803-2673-4E8E-B053-B5B00EDBBC09 Q37659134-F75C6022-2940-4469-9AC8-8DAEEB52B899 Q37690768-400E05D6-E84D-4668-81F1-B0BBBF0C3763 Q37970704-7B359413-3E34-4E4B-BDBB-D52E565A1C84 Q38171069-52AE6521-F54A-453F-B36D-D81B87AD1E90 Q38359256-943EA1C1-36E7-409D-B4FA-C9C9EFCD3DCF Q38783047-64CFFDCB-44EA-427D-91F7-DA066ECB7D4A Q40270663-EB4102D3-A7AE-4EF4-B48C-F424BD3901B2 Q41124782-C58673AE-6759-4B85-8B2A-9ECF32A6E856 Q42175889-9FAFA66C-D38C-449E-8558-98EE0661CAF2 Q43483228-B0877A0A-2CD7-4329-968F-8B6E4C16A9C3 Q46012379-3B973CFA-387A-4DC2-9D6C-BC9CCCAB0967 Q46799529-7480B876-2F4B-4402-AEA6-AD8229C2AA61 Q47332881-D7316C6F-854B-48A0-9559-0CD8950EBBC1

P2860

Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases

http://www.wikidata.org/entity/Q28383084

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Emerging infectious diseases: ...... llergy and Infectious Diseases

@ast

Emerging infectious diseases: ...... llergy and Infectious Diseases

@en

Emerging infectious diseases: ...... llergy and Infectious Diseases

@nl

type

label

Emerging infectious diseases: ...... llergy and Infectious Diseases

@ast

Emerging infectious diseases: ...... llergy and Infectious Diseases

@en

Emerging infectious diseases: ...... llergy and Infectious Diseases

@nl

prefLabel

Emerging infectious diseases: ...... llergy and Infectious Diseases

@ast

Emerging infectious diseases: ...... llergy and Infectious Diseases

@en

Emerging infectious diseases: ...... llergy and Infectious Diseases

@nl

P1433

Q28383084-681A38DA-84CD-4445-800B-C501A896F766

P1476

Q28383084-3E4AFFD5-424A-47F1-881F-84139D0ECF92

P2093

Q28383084-12B63271-F41B-46F1-B4C4-F6BCC954C33F

P2860

Q28383084-0D46A275-BA4B-4D12-9E44-4EAA69E6C16D

Q28383084-11186441-43A0-4F73-8699-AB7714CFED06

Q28383084-1948B13D-3DAF-4A40-B47B-86AAFE449124

Q28383084-3141E7F3-E567-4E8A-96C5-3BE361855D53

Q28383084-386AB8A7-BED3-45F6-914C-5BE6AD2AAB9B

Q28383084-41BF4F84-93F4-4D1D-9B23-6759C2A652C7

Q28383084-424BB8A6-6746-4507-8351-10F81765A07D

Q28383084-431AA36B-610B-42EB-B520-B4E78626BC8E

Q28383084-4954956C-D0F4-474D-9C44-8915823A6DC0

Q28383084-567E0D17-C4FC-445F-92A9-E2B313ADC472

P304

Q28383084-7F1C20F4-5BCE-4874-BA57-FD8936541F7D

P31

Q28383084-72565175-3464-4665-9207-8BAEA063CFEF

P3181

Q28383084-0895721C-BCF4-428C-8E12-5387CF398E47

P356

Q28383084-1FD2AF9E-E4C3-40C7-8275-AA1E67C90129

P407

Q28383084-FE32CCA7-636E-4A83-A510-08EE855EC4D7

P433

Q28383084-E044FCA2-B655-4D47-B6E1-BCB6D4235CFB

P478

Q28383084-F4BF6CC6-3C1F-4F55-B845-70B6A61EF1A9

P50

Q28383084-2D8E267D-AC41-4EE4-960E-54180E3E80EE

Q28383084-E8080AC2-E231-4812-9A1E-E46F22F8A1B1

P577

Q28383084-BF7E5677-F948-46D7-ADEB-3F19D4EDD6FC

P5875

Q28383084-113C8E25-52D3-4E70-AD58-DE80A24E0DC1

P698

Q28383084-2FA48BED-F705-4141-8DCC-47E2DB21BE7C

P921

Q28383084-A1ACA376-9227-4547-853D-B61F5B9BC0B9

P932

Q28383084-9771E278-F41E-4077-AA93-75D174D2487C

P3181

P356

P1433

Emerging Infectious Diseases

P1476

Emerging infectious diseases: ...... llergy and Infectious Diseases

@en

P2093

Nancy A Touchette

http://www.w3.org/2001/XMLSchema#string

P2860

The Genome Sequence of the Malaria Mosquito Anopheles gambiae

Genome sequence of the human malaria parasite Plasmodium falciparum

A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis

Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings

Treatment of West Nile Virus Encephalitis with Intravenous Immunoglobulin

Evidence for a Central Role for PfCRT in Conferring Plasmodium falciparum Resistance to Diverse Antimalarial Agents

The challenge of emerging and re-emerging infectious diseases

Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

P304

519-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1875782

http://www.w3.org/2001/XMLSchema#string

P356

10.3201/EID1104.041167

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Gregory K Folkers

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7908234

http://www.w3.org/2001/XMLSchema#string

P698

15829188

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

3320336

http://www.w3.org/2001/XMLSchema#string